Trading volume reached 1.4 million shares, above its 50-day average of 1.1 million, though the stock remains 21.8% below its 52-week high of $556.52 set on 12 March.
Facing a $900M policy hit, can HCA’s AI strategy unlock its deeply undervalued stock?
As HCA's market dominance grows, are patients facing care that is too expensive to afford?